Estro-Cyp Interactions
There are 363 drugs known to interact with Estro-Cyp (estradiol), along with 17 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 29 are major, 314 are moderate, and 20 are minor.
- View all 363 medications that may interact with Estro-Cyp
- View Estro-Cyp alcohol/food interactions (3)
- View Estro-Cyp disease interactions (17)
Most frequently checked interactions
View interaction reports for Estro-Cyp (estradiol) and the medicines listed below.
- Acidophilus (lactobacillus acidophilus)
- aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide
- amitriptyline
- Byetta (exenatide)
- carisoprodol
- clonazepam
- Cozaar (losartan)
- Culturelle DS (lactobacillus rhamnosus gg)
- Effexor XR (venlafaxine)
- Evista (raloxifene)
- hydrochlorothiazide
- Lantus (insulin glargine)
- Lexapro (escitalopram)
- Lyrica (pregabalin)
- magnesium amino acids chelate
- meloxicam
- metformin
- milk thistle
- Nexium (esomeprazole)
- Norco (acetaminophen / hydrocodone)
- Novolog (insulin aspart)
- Osteo Bi-Flex Plus MSM (chondroitin / glucosamine / methylsulfonylmethane)
- oxycodone
- papaya
- Soma (carisoprodol)
- Synthroid (levothyroxine)
- trazodone
- VESIcare (solifenacin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
Estro-Cyp alcohol/food interactions
There are 3 alcohol/food interactions with Estro-Cyp (estradiol).
Estro-Cyp disease interactions
There are 17 disease interactions with Estro-Cyp (estradiol) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Estro-Cyp (estradiol)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogens
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.